M89, a combination of 89% of vichy volcanic mineralizing water and hyaluronic acid improves signs and symptoms of subjects with rosacea/sensitive/reactive skin: results from an open-label, observational, international study

  • 10min
  • May. 2022
  • Supported by
  • Laboratoires Vichy

INTRODUCTION

Rosacea is a common chronic inflammatory skin disease characterised by persistent erythema associated with periodic intensification or ‘flares’. The syndrome of sensitive or reactive skin is characterized by abnormal and unpleasant sensations, such as burning, stinging, and itching, manifests as exaggerated responses to stimuli. Sensitive skin may occur in individuals with normal skin, with skin barrier disturbance, or as a part of the symptoms associated with rosacea, atopic dermatitis and psoriasis. M89 contains 89% Vichy volcanic mineralizing water and 0.4% hyaluronic acid in a minimalist formulation was developed to reinforce the skin barrier and to protect against exposome factors. It is hypoallergenic and contains no perfume, thus being suitable for subjects with rosacea. It reinforces the natural defences of the skin in restoring the natural skin barrier, stimulating antioxidant activity and reducing inflammation, which is commonly observed in subjects with rosacea. Recent interim analysis of this large international study conducted in subjects with inflammatory dermatoses or having undergone dermatological procedures confirmed the benefit and excellent tolerance of M89.


Jerry Tan, Julieta Spada, Cecilia Orlandi, Martina Kerscher, Maryna Anfilova, Sonya Abdulla, Anita Altmeyer, Catherine Delva, Delphine Kerob, Maiia Goldobina10, Elena Araviiskaia